Moreover, RAC1 is activated in rhabdomyosarcoma cell lines, and overexpression of dominant‐negative forms inhibits cell proliferation of RMS.22 Therefore, a potential interaction of DEPDC1B and RAC1 could occur in muscle. Here, DEPDC1B is linked to rhabdomyosarcoma.